Biomedika
Vol 17, No 1 (2025): Biomedika August 2025

THE RELATIONSHIP BETWEEN BLOOD PRESSURE LEVELS AND THE INCIDENCE OF DIABETIC NEUROPATHY IN TYPE-2 DIABETES MELLITUS PATIENTS.

Indriyani, Putri (Unknown)
Yuliyanasari, Nurma (Unknown)
Kartikasari, Irma (Unknown)
Irfana, Laily (Unknown)



Article Info

Publish Date
30 Aug 2025

Abstract

Diabetic neuropathy (DN) is microvascular complications in people with type 2 diabetes that can significantly affect patients’ quality of life. Higher levels of blood pressure are known to be associated with an increased occurrence of diabetic neuropathy in type 2 diabetes patients. This study aimed to determine the risk factors for blood pressure levels with the incidence of diabetic neuropathy. This approach used purposive sampling with a cross-sectional methodology. SPSS version 26 with the chi square test was used to analyze the data. This study involved 68 patient. Patient with diabetic neuropathy mostly female (23.8%), aged of 51-60 years (16.2%), have had diabetes for > 5 years (22.1%), consumed insulin or anti-diabetic medications orally (35.5%), have a history of hypertension (20.6%), and do not take antihypertensive drugs (20.6%). ccording to the findings of the ci-squre analysis, there was a significant correlation between the incidence of diabetic neuropathy and the level of blood pressure (p < 0.04). Patients who suffer from neuropathy diabetic had the most hypertension grade 1. Meanwhile, patients who do not had diabetic neuropathy mostly have optimal, normal and normal-high blood pressure. In conclusion, there is a correlation between the incidence of blood pressure levels and diabetic neuropathy.

Copyrights © 2025






Journal Info

Abbrev

biomedika

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Description

Biomedika is one of the efforts of the Faculty of Medicine of University Muhammadiyah Surakarta to improve the academic atmosphere, as a publication of research results from lecturers and students. The existence of Biomedika is expected to enhance the activity and quality of research in medical and ...